Open AccessCan we change autoimmunity in Type 1 Diabetes via insulin injection or oral insulin?
Author(s) -
Muyun Cao
Publication year - 2019
Publication title -
journal of medical research and innovation
Language(s) - English
Resource type - Journals
ISSN - 2456-8139
DOI - 10.32892/jmri.196
Subject(s) - proinsulin , autoimmunity , insulin , medicine , type 1 diabetes , diabetes mellitus , type 2 diabetes , immune system , autoimmune disease , disease , immunology , endocrinology
This article reviews recent immunotherapy studies of Type 1 Diabetes (T1D) which is an autoimmune disease. Researchers show that injecting human proinsulin peptides can safely modulate the immune system and affect beta-cell function in Type 1 Diabetes, but oral insulin consumption does not reduce the onset of Type 1 Diabetes in individuals at the early stage of the disease.